COMMUNICATIONS
M.p. 127.88C; [a]D20
37.29 (c 1.00 in dichloromethane); 1H NMR
is less stable than A. Within this model, the desired 3,5-trans
product, the result of a cyclization via A, should be formed in
slight excess, which is indeed the case (Table 1). Structural
verification was again achieved by X-ray structure analysis of
the minor compounds 5-epi-19a and 5-epi-18a, confirming the
predicted 3,5-cis relative configuration.[24]
(270 MHz, [D10]xylol, 808C): d 0.849 (d, 3J 6.9 Hz, 3H; 4-CH3), 1.230
(d, 3J 6.1 Hz, 3H; 5-CH3), 1.448 (s, 9H; C(CH3)3), 1.618 (dqq, 3J 8.8,
3
3
2
3J 6.9, J 6.1 Hz, 1H; 4-H), 2.459 (dd, J 9.4, J 13.6 Hz, 1H; A-H),
3
2
3
3
2.988 (dd, J 4.6, J 13.6 Hz, 1H; B-H), 3.427 (dq, J 8.8, J 6.1 Hz,
1H; 5-H), 3.591 (brs, 1H; 3-H), 3.934 (ddd, 3J 9.4, 3J 4.6, 3J 5.7 Hz,
1H; 2-H), 7.013 ± 7.177 (m, 5H; arom.); 13C NMR (67.9 MHz, [D10]xylol,
808C): d 11.12 (C-4'), 19.44 (C-5'), 28.88 (C(CH3)), 40.97 (C-A/B), 44.62
(C-4), 59.33 (C-5), 69.46 (C-2), 75.73 (C-3), 79.00 (C(CH3)), 126.71, 128.63,
129.23 (5C, arom.), 139.75 (ipso-arom.), 154.49 (C O); IR (KBr): nÄ
Our results can be summerized as follows:
1) The g-hydroxyalkylation of the enantiomeric allyl- and
crotylsulfoximides 2a/3a and ent-2a/ent-3a, respectively, with
a-aminoaldehydes results in the formation of isomerically
pure vinylsulfoximides 14 and 15, which can be transformed to
highly substituted pyrrolidines 16 and 17 with piperidine as a
deblocking agent.
3430.1 (OH), 2973.0, 2930.6 (CH3), 1672.4 (C O) cm 1; elemental analysis
calcd for C18H27NO3 (305.41): C 70.79, H 8.91, N 4.59; found: C 70.59, H
8.93, N 4.63.
Received: May 28, 1998 [Z11917IE]
German version: Angew. Chem. 1998, 110, 3005 ± 3008
2) The absolute configuration at the newly formed stereo-
genic centers C-3 and C-4 is controlled by the absolute
configuration at sulfur (reagent control). The configuration at
C-5 is the result of conformational preferences of the
cyclization precursor. Therefore only 3-substituted derivatives
allow total control of this stereogenic center.
Keywords: asymmetric synthesis ´ heterocycles ´ pyrroli-
dines ´ samarium ´ sulfoximines
[1] a) M. Reggelin, H. Weinberger, Tetrahedron Lett. 1992, 33, 6959 ±
6962; b) M. Reggelin, R. Welcker, Tetrahedron Lett. 1995, 36, 5885 ±
5886.
[2] M. Reggelin, H. Weinberger, Angew. Chem. 1994, 106, 489 ± 491;
Angew. Chem. Int. Ed. Engl. 1994, 33, 444 ± 446.
[3] a) M. Reggelin, H. Weinberger, M. Gerlach, R. Welcker, J. Am. Chem.
Soc. 1996, 118, 4765 ± 4777; b) M. Reggelin, M. Gerlach, M. Vogt,
unpublished results.
[4] M. Reggelin, H. Weinberger, T. Heinrich, Liebigs Ann. 1997, 1881 ±
1886.
[5] W. H. Pearson in Studies in Natural Product Chemistry, Vol. 1 (Ed.:
Atta-Ur-Rahman), Elsevier, Amsterdam, 1988, pp. 323 ± 358.
[6] a) G. W. Fleet, Top. Med. Chem. 1988, 65, 149 ± 162; b) R. T. Schwarz,
R. Datema, Trends Biochem. Sci. 1984, 9, 32 ± 34; c) V. Wehner, V.
Jäger, Angew. Chem. 1990, 102, 1180 ± 1182; Angew. Chem. Int. Ed.
Engl. 1990, 29, 1169 ± 1171, and references therein.
3) Samarium diiodide was introducted as a superior desulfur-
ation agent.
The expansion of this new strategy to synthesize isomeri-
cally pure, saturated nitrogen heterocycles such as substituted
1- and 2-azabi- and -tricyclic derivatives by proper combina-
tion of open-chain or cyclic 2-alkenylsulfoximides with open-
chain or cyclic a-aminoaldehydes was already successful (e.g.
12, 13, Scheme 1) and will be published in due course.
Furthermore, we found that with certain pharmacophoric
substituents R2 and after installation of such substituents at
the free OH group (e.g. by benzylation), a number of
biologically active substances are available.[25]
[7] R. J. Bridges, F. E. Lovering, J. M. Humphrey, M. S. Stanley, T. N.
Blakely, M. F. Cristopharo, A. R. Chamberlin, Bioorg. Med. Chem.
Lett. 1993, 3, 115 ± 121, and references therein.
Experimental Section
[8] a) E. W. Petrillo, M. A. Ondetti, Med. Res. Rev. 1982, 2, 1 ± 41; b) H. S.
Cheung, D. W. Cushman, Biochim. Biophys. Acta. 1973, 293, 451 ± 463.
[9] K. Soai, S. Niwa, Chem. Rev. 1992, 92, 833 ± 856.
[10] E. J. Corey, R. K. Bakshi, S. J. Shibata, J. Am. Chem. Soc. 1987, 105,
5551 ± 5553.
18d: To a solution of 3a (329 mg, 0.89 mmol) in toluene (2 mL) was added
1
nBuLi (492 mg, 2.27 mmolg in hexane) at 788C by syringe. After
15 min ClTIPT (487 mg, 2.50 mmolg 1) was added, and the mixture was
warmed to 08C and stirred for 30 min. The mixture was again cooled to
788C, 21a (754 mg, 1.79 mmol) dissolved in THF (3 mL) was added, and
[11] S. Kobayashi, M. Murakami, T. Harada, T. Mukayama, Chem. Lett.
1991, 1341 ± 1344.
the mixture was stirred at
788C for 60 min. Piperidine (0.9 mL,
8.90 mmol) was added, and the temperature was raised to 08C. After
10 h the reaction mixture was poured onto a well-mixed, saturated solution
of (NH4)2CO3 (25 mL) layered with ethyl acetate (4 mL). After 30 min two
clear phases could be separated. The aqueous phase was extracted three
times with ethyl acetate (10 mL), and the combined organic layers were
extracted with a saturated solution of NH4Cl. After the organic phase was
dried over Na2SO4 and the solvent was evaporated in vacuo, the
benzofulvene ± piperidine adduct was crystallized from methanol. The
resulting crude product was purified by column filtration (eluent: diethyl
ether/hexane 1/1; ethyl acetate), and the obtained polar fraction was
treated with K2CO3 (136 mg, 0.99 mmol) in methanol (3 mL). The
pyrrolidine (desilylated 3a) nitrogen atom was protected with di-tert-
butoxycarbonate (BOC2O, 350 mg, 1.60 mmol) and NaHCO3 (100 mg,
1.2 mmol) in dioxane (4 mL) and water (8 mL). Then residual 3a and
unchanged BOC2O were removed by flash chromatography.
Á
[12] M. Pichon, B. Figadere, Tetrahedron: Asymmetry 1996, 7, 927 ± 964.
[13] a) R. H. Wightman, Tetrahedron 1993, 49, 3827 ± 3840; b) F. Nicotra,
Tetrahedron Lett. 1993, 34, 4555 ± 4558; c) C. Kibayashi, J. Org. Chem.
1987, 32, 1956 ± 1962; d) T. Livinghouse, J. Am. Chem. Soc. 1993, 115,
11458 ± 11489.
[14] a) P. Deprez, J. Royer, H. P. Husson, Tetrahedron: Asymmetry 1991, 2,
1189 ± 1192; b) P. Garner, W. B. Ho, J. Org. Chem. 1990, 55, 3973 ±
3975; c) P. Garner, F. Arya, W. B. Ho, J. Org. Chem. 1990, 55, 412 ±
414; d) R. M. Williams, W. Zhai, D. Aldous, S. C. Aldous, J. Org.
Chem. 1992, 57, 6527 ± 6532, zit. Lit.; e) W. J. Lown in 1,3-Dipolar
Cycloaddition Chemistry, Vol. 1 (Ed.: A. Padwa), Wiley, New York,
1984.
[15] a) G. Liu, J. A. Ellman, J. Org. Chem. 1995, 60, 7712 ± 7713. b) M. M.
Murphy, J. R. Schullek, E. M. Gordon, M. A. Gallop, J. Am. Chem.
Soc. 1995, 117, 7029 ± 7030.
[16] a) D. B. Dess, J. C. Martin, J. Am. Chem. Soc. 1991, 113, 7277 ± 7287;
b) D. B. Dess, J. C. Martin, J. Org. Chem. 1983, 48, 4156 ± 4158.
[17] After addition of 84 mol% of the chiral shift reagent Pr(hfc)3, the
enantiomeric excess of the aldehydes could be determined by
integration of the 1H NMR signal of the aldehyde protons: M.
Reggelin, T. Heinrich, unpublished results.
[18] Raney Nickel requires a large excess (>10 equiv) to provide satisfying
results, and much of the pyrrolidine formed is absorbed. Lithium
naphthalenide works fast, but ring-opened by-products are formed.
To remove the chiral auxiliary samarium (545 mg, 3.63 mmol) was
suspended in THF (12 mL), and diiodomethane (860 mg, 3.21 mmol) was
added by syringe at 08C. After 15 min the reaction was maintained at room
temperature for 60 min, and the pyrrolidine was added in methanol
(1.5 mL) and THF (3 mL). To quench the reaction, the mixture was poured
into a saturated solution of NH4Cl (20 mL), and 0.5n HCl was added until
two clear phases resulted. After the organic layer was extracted three times
with diethyl ether (20 mL), and the pyrrolidine was purified by flash
chromatography (diethyl ether/hexane 1/1) to yield 129 mg of 18d (63%).
Angew. Chem. Int. Ed. 1998, 37, No. 20
ꢀ WILEY-VCH Verlag GmbH, D-69451 Weinheim, 1998
1433-7851/98/3720-2885 $ 17.50+.50/0
2885